Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium

• Published in: Schizophrenia research Vol. 204; pp. 96 - 103
• Main Authors: Cadenhead, Kristin S., Minichino, Amedeo, Kelsven, Skylar, Addington, Jean, Bearden, Carrie, Cannon, Tyrone D., Cornblatt, Barbara A., Mathalon, Dan, McGlashan, Thomas H., Perkins, Diana O., Seidman, Larry J., Tsuang, Ming, Walker, Elaine F., Woods, Scott W., Yao, Jeff
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.02.2019
• Subjects: Adolescent; Adult; Child; Clinical high risk; Diabetes Mellitus - epidemiology; Diabetes Mellitus - ethnology; Double-Blind Method; Dyslipidemias - epidemiology; Dyslipidemias - ethnology; Fatty acid; Fatty Acids, Omega-3; Female; Humans; Hypertension - epidemiology; Hypertension - ethnology; Male; Metabolic; Metabolic Syndrome - epidemiology; Metabolic Syndrome - ethnology; Omega 3; Overweight - epidemiology; Overweight - ethnology; Oxidative stress; Prediabetic State - epidemiology; Prehypertension - epidemiology; Prodromal Symptoms; Risk; Severity of Illness Index; Young Adult; Omega 3; Oxidative stress; Metabolic; Clinical high risk; Fatty acid
• ISSN: 0920-9964; 1573-2509; 1573-2509
• DOI: 10.1016/j.schres.2018.09.022

Patients with schizophrenia have a high prevalence of metabolic disorders and cardiovascular mortality. It is possible that a vulnerability to metabolic abnormalities is associated with risk for psychosis, symptoms and functionality. In this study, we evaluate demographic information, cardiometaboli...